Clinical Trial Update: Phosphorylation of ERK1/2 in Patients With Parkinson's Disease

View source ↗

Summary

A completed clinical trial evaluating phosphorylation of ERK1/2 in patients with Parkinson disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Snippet

Sponsor: University Hospital, Bordeaux | Conditions: Parkinson Disease | Status: COMPLETED